Choosing drugs for UK COVID-19 treatment trials

Chinnery, Patrick F., Bonnet, Marion, Cave, Alison, Hofer, Matthias P., Lamb, Alastair, McConkey, Glenn A., Medcalf, Nicholas, Smith, Stephen P., Tsakok, Teresa, Watson, Robert, Webster, Steve and You, Tao 2021. Choosing drugs for UK COVID-19 treatment trials. Nature Reviews Drug Discovery 10.1038/d41573-021-00203-7

Preview	PDF - Accepted Post-Print Version Download (276kB) | Preview
Preview	PDF - Supplemental Material Download (327kB) | Preview

Abstract

In 2020, the UK government funded a portfolio of platform trials to develop new treatments for COVID-19. A key feature was the independent prioritization of candidate drugs with central coordination to prevent duplication, accelerating recruitment to deliver definitive trial results. A similar approach could be used for non-communicable diseases where treatment advances have been limited.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Nature Research
ISSN:	1474-1776
Date of First Compliant Deposit:	23 February 2022
Last Modified:	14 Jun 2022 04:53
URI:	https://orca.cardiff.ac.uk/id/eprint/146157

Actions (repository staff only)

Edit Item